Your Roku has hidden settings and menu screens - here's how to unlock them ...
A recent review published in the journal Current Clinical Microbiology Reports discussed how modern lifestyle factors affect the microbiome. Changes in the metabolomic output and composition of the ...
Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have designed a group of potential diabetes drugs that reprogram ...
From Jack Dorsey to Gen Alpha, everyone seemingly wants to go back to the internet of a decade ago. But is it possible to reverse AI slop and brain rot? Which implies, of course, that memes lack ...
GLP-1 is the naturally produced hormone whose function is being mimicked by drugs like semaglutide and tirzepatide, the active ingredients in popular and highly effective weight-loss drugs like Wegovy ...
Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective T reg cells. These cells help ensure that the ...
The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...
The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...
Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...
Across much of America, workers fear their options for remote work are slipping away. But remote work is alive and well, at least for now. Five years into the pandemic workplace revolution, roughly 38 ...
A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists (RAs), ...